Clinical Trial Update: Retrograde Delivery of BMAC (Bone Marrow Aspirate Concentrate) for Congestive Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 trial assessing retrograde delivery of bone marrow aspirate concentrate (BMAC) for congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Bone Marrow Aspirate Concentrate (BMAC) (bone marrow aspirate concentrate)

Snippet

Sponsor: Harvest Technologies | Conditions: Congestive Heart Failure | Phase 1 | Status: COMPLETED